Retrospective review reveals challenges in diagnosing and treating hepatitis-associated aplastic anemia in children, suggesting the need for prompt intervention.
Key Points
Early intervention is crucial as hepatitis-associated aplastic anemia can rapidly progress to severe cases.
Among five pediatric patients, four experienced severe aplastic anemia and high reliance on stem cell transplantation.
Observational analysis focused on clinical presentations, treatments, and outcomes over a median follow-up of 2.5 years.
This highlights the need for further research to optimize treatment strategies for hepatitis-associated aplastic anemia.